Please login to the form below

Not currently logged in
Email:
Password:

Chimerix

This page shows the latest Chimerix news and features for those working in and with pharma, biotech and healthcare.

Merck says drug for CMV in transplant patients hits targets

Merck says drug for CMV in transplant patients hits targets

The company's good news comes after another CMV drug developer - Chimerix - reported that its brincidofovir CMV candidate failed a pair of pivotal trials.

Latest news

  • Chimerix hit as lead drug brincidofovir flunks trial Chimerix hit as lead drug brincidofovir flunks trial

    Patients in the brincidofovir arm also showed an increase in mortality compared to the control arm, but the increase was not statistically significant, according to Chimerix. ... Both GVHD and use of corticosteroids are risk factors for 'late' CMV

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Pharma deals during July 2012 Pharma deals during July 2012

    Anti-infective deals. A similar size to the Genmab deal at $168m is the agreement between Chimerix, a US based private company developing antiviral therapies and Merck &Co. ... 178. Chimerix / Merck &Co. Licence. Lipid antiviral conjugate in phase 1 for

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Former Glaxo CEO Ernest Mario to chair Chimerix Former Glaxo CEO Ernest Mario to chair Chimerix

    Chimerix has appointed pharma veteran and former CEO of Glaxo Holdings Dr Ernest Mario as the company's new chairman. ... Dr Mario replaces Dr James Niedel, who will remain as a member of the board at Chimerix.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...